Cargando…
Lentiviral-Driven Discovery of Cancer Drug Resistance Mutations
Identifying resistance mutations in a drug target provides crucial information. Lentiviral transduction creates multiple types of mutations due to the error-prone nature of the HIV-1 reverse transcriptase (RT). Here we optimized and leveraged this property to identify drug resistance mutations, deve...
Autores principales: | Yenerall, Paul, Kollipara, Rahul K., Avila, Kimberley, Peyton, Michael, Eide, Christopher A., Bottomly, Daniel, McWeeney, Shannon K., Liu, Yan, Westover, Kenneth D., Druker, Brian J., Minna, John D., Kittler, Ralf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8448967/ https://www.ncbi.nlm.nih.gov/pubmed/34301758 http://dx.doi.org/10.1158/0008-5472.CAN-21-1153 |
Ejemplares similares
-
HitWalker: variant prioritization for personalized functional cancer genomics
por: Bottomly, Daniel, et al.
Publicado: (2013) -
plethy: management of whole body plethysmography data in R
por: Bottomly, Daniel, et al.
Publicado: (2015) -
HitWalker2: visual analytics for precision medicine and beyond
por: Bottomly, Daniel, et al.
Publicado: (2016) -
ERBB2/HER2 mutations are transforming and therapeutically targetable in leukemia
por: Joshi, Sunil K., et al.
Publicado: (2020) -
Identification of β-catenin binding regions in colon cancer cells using ChIP-Seq
por: Bottomly, Daniel, et al.
Publicado: (2010)